Kidney International · 2023 · 52 citations · 37 references
Life SciencesImmunologyMolecular BiologyAutoimmunityInnate ImmunitySignal TransductionImmune SignalingInflammatory SignalingMacrophage BiologyRenal DiseaseRenal InflammationSystemic Lupus ErythematosusCellular Inflammatory ResponsesDamage-associated Molecular PatternsHypertonic Stress ResponseImmunopathology Of Renal DiseaseKidney Biopsy FindingsKidney DiseasesRenal Inflammatory InjuryToll-like Receptors In Inflammation
Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by autoreactive B cells and dysregulation of many other types of immune cells including myeloid cells. Lupus nephritis (LN) is a common target organ manifestations of SLE. Tonicity-responsive enhancer-binding protein (TonEBP, also known as nuclear factor of activated T-cells 5 (NFAT5)), was initially identified as a central regulator of cellular responses to hypertonic stress and is a pleiotropic stress protein involved in a variety of immunometabolic diseases. To explore the role of TonEBP, we examined kidney biopsy samples from patients with LN. Kidney TonEBP expression was found to be elevated in these patients compared to control patients – in both kidney cells and infiltrating immune cells. Kidney TonEBP mRNA was elevated in LN and correlated with mRNAs encoding inflammatory cytokines and the degree of proteinuria. In a pristane-induced SLE model in mice, myeloid TonEBP deficiency blocked the development of SLE and LN. In macrophages, engagement of various toll-like receptors (TLRs) that respond to damage-associated molecular patterns induced TonEBP expression via stimulation of its promoter. Intracellular signaling downstream of the TLRs was dependent on TonEBP. Therefore, TonEBP can act as a transcriptional cofactor for NF-κB, and activated mTOR-IRF3/7 via protein-protein interactions. Additionally, TonEBP-deficient macrophages displayed elevated efferocytosis and animals with myeloid deficiency of TonEBP showed reduced Th1 and Th17 differentiation, consistent with macrophages defective in TLR signaling. Thus, our data show that myeloid TonEBP may be an attractive therapeutic target for SLE and LN. Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by autoreactive B cells and dysregulation of many other types of immune cells including myeloid cells. Lupus nephritis (LN) is a common target organ manifestations of SLE. Tonicity-responsive enhancer-binding protein (TonEBP, also known as nuclear factor of activated T-cells 5 (NFAT5)), was initially identified as a central regulator of cellular responses to hypertonic stress and is a pleiotropic stress protein involved in a variety of immunometabolic diseases. To explore the role of TonEBP, we examined kidney biopsy samples from patients with LN. Kidney TonEBP expression was found to be elevated in these patients compared to control patients – in both kidney cells and infiltrating immune cells. Kidney TonEBP mRNA was elevated in LN and correlated with mRNAs encoding inflammatory cytokines and the degree of proteinuria. In a pristane-induced SLE model in mice, myeloid TonEBP deficiency blocked the development of SLE and LN. In macrophages, engagement of various toll-like receptors (TLRs) that respond to damage-associated molecular patterns induced TonEBP expression via stimulation of its promoter. Intracellular signaling downstream of the TLRs was dependent on TonEBP. Therefore, TonEBP can act as a transcriptional cofactor for NF-κB, and activated mTOR-IRF3/7 via protein-protein interactions. Additionally, TonEBP-deficient macrophages displayed elevated efferocytosis and animals with myeloid deficiency of TonEBP showed reduced Th1 and Th17 differentiation, consistent with macrophages defective in TLR signaling. Thus, our data show that myeloid TonEBP may be an attractive therapeutic target for SLE and LN. Lay SummarySystemic lupus erythematosus (SLE) is a complex and clinically heterogeneous autoimmune disease caused by dysregulated innate and adaptive immune systems. Here, we show that tonicity-responsive enhancer-binding protein (TonEBP) is an autoimmune stress protein that mediates damage-associated molecular pattern–mediated signaling in macrophages, leading to skewing of T-cell populations in SLE and lupus nephritis (LN). LN is a common and severe manifestation of SLE associated with both acute kidney injury and chronic kidney disease. In patients with LN, TonEBP expression was elevated in both renal cells and infiltrating immune cells, including macrophages. Elevated renal TonEBP was associated with renal inflammation and local injury, suggesting that it may be an attractive therapeutic target. Systemic lupus erythematosus (SLE) is a complex and clinically heterogeneous autoimmune disease caused by dysregulated innate and adaptive immune systems. Here, we show that tonicity-responsive enhancer-binding protein (TonEBP) is an autoimmune stress protein that mediates damage-associated molecular pattern–mediated signaling in macrophages, leading to skewing of T-cell populations in SLE and lupus nephritis (LN). LN is a common and severe manifestation of SLE associated with both acute kidney injury and chronic kidney disease. In patients with LN, TonEBP expression was elevated in both renal cells and infiltrating immune cells, including macrophages. Elevated renal TonEBP was associated with renal inflammation and local injury, suggesting that it may be an attractive therapeutic target. Systemic lupus erythematosus (SLE) is a highly complex and heterogeneous chronic autoimmune disease. Lupus nephritis (LN), characterized by severe inflammation in the kidney with deposition of immune complexes, is a major risk factor for morbidity and mortality in SLE.1Maroz N. Segal M.S. Lupus nephritis and end-stage kidney disease.Am J Med Sci. 2013; 346: 319-323Abstract Full Text Full Text PDF PubMed Scopus (143) Google Scholar The central function of lymphocytes in SLE is well described: hyperactivated autoantibody-producing B cells and an imbalance of T-cell subsets that contribute to loss of immune tolerance.2Munoz L.E. Lauber K. Schiller M. et al.The role of defective clearance of apoptotic cells in systemic autoimmunity.Nat Rev Rheumatol. 2010; 6: 280-289Crossref PubMed Scopus (485) Google Scholar, 3Dorner T. Giesecke C. Lipsky P.E. Mechanisms of B cell autoimmunity in SLE.Arthritis Res Ther. 2011; 13: 243Crossref PubMed Scopus (202) Google Scholar, 4Mak A. Kow N.Y. The pathology of T cells in systemic lupus erythematosus.J Immunol Res. 2014; 2014419029Crossref PubMed Scopus (135) Google Scholar Myeloid cells also contribute to the pathogenesis of SLE. Macrophages are defective in eliminating dying cells via phagocytosis (termed efferocytosis) and drive the proinflammatory milieu in SLE.5Herrmann M. Voll R.E. Zoller O.M. et al.Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus.Arthritis Rheum. 1998; 41: 1241-1250Crossref PubMed Scopus (721) Google Scholar, 6Gaipl U.S. Munoz L.E. Grossmayer G. et al.Clearance deficiency and systemic lupus erythematosus (SLE).J Autoimmun. 2007; 28: 114-121Crossref PubMed Scopus (242) Google Scholar, 7Munoz L.E. Chaurio R.A. Gaipl U.S. et al.MoMa from patients with systemic lupus erythematosus show altered adhesive activity.Autoimmunity. 2009; 42: 269-271Crossref PubMed Scopus (13) Google Scholar Also, as antigen-presenting cells, they process and present autoantigens to T cells in conjunction with major histocompatibility complex (MHC), or costimulatory molecules on the cell surface,8Relle M. Schwarting A. Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus.Clin Dev Immunol. 2012; 2012584374Crossref PubMed Scopus (33) Google Scholar, 9Wang J. Xie L. Wang S. et al.Azithromycin promotes alternatively activated macrophage phenotype in systematic lupus erythematosus via PI3K/Akt signaling pathway.Cell Death Dis. 2018; 9: 1080Crossref PubMed Scopus (39) Google Scholar, 10Burbano C. Villar-Vesga J. Vasquez G. et al.Proinflammatory differentiation of macrophages through microparticles that form immune complexes leads to T- and B-cell activation in systemic autoimmune diseases.Front Immunol. 2019; 10: 2058Crossref PubMed Scopus (31) Google Scholar leading to T-cell differentiation. Toll-like receptors (TLRs), widely expressed by various immune cell types, recognize pathogen- and damage-associated molecular patterns and initiate inflammatory responses. Studies in mouse models show that TLR4, TLR7/8, and TLR9 contribute to the pathogenesis of SLE.11Summers S.A. Hoi A. Steinmetz O.M. et al.TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.J Autoimmun. 2010; 35: 291-298Crossref PubMed Scopus (102) Google Scholar, 12Savarese E. Steinberg C. Pawar R.D. et al.Requirement of toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.Arthritis Rheum. 2008; 58: 1107-1115Crossref PubMed Scopus (116) Google Scholar, 13Patole P.S. Zecher D. Pawar R.D. et al.G-rich DNA systemic PubMed Scopus Google Scholar in these genes and a to SLE in L. et of TLR4 TLR9 and with risk for systemic lupus erythematosus PubMed Scopus (31) Google Scholar, et in toll-like receptors are associated with systemic lupus erythematosus in a 2014; PubMed Scopus Google Scholar, A. et toll-like receptors are associated with systemic lupus erythematosus in a of 2014; PubMed Scopus Google Scholar and a of human Wang et human PubMed Scopus Google Scholar of our of TLR in SLE is on B lymphocytes and cells, it is to explore the function of TLRs in macrophages. Tonicity-responsive enhancer-binding protein also known as nuclear factor of activated T cells was initially identified as a central regulator of cellular responses to hypertonic et a protein that in to A. PubMed Scopus Google Scholar, et stress as a of the A. PubMed Scopus Google Scholar, et cellular for to hypertonic and J 2011; PubMed Scopus Google Scholar in and show that expression of TonEBP mediates the pathogenesis of inflammatory and autoimmune by to the development and activation of immune cells in and The role of TonEBP as an immunometabolic stress Rev PubMed Scopus Google Scholar In macrophages, TonEBP is induced by inflammatory as or S. et DNA S. et enhancer-binding protein mediates inflammation and and renal 2018; PubMed Scopus Google Scholar differentiation the phenotype via stimulation of nuclear factor a transcriptional for the and et et the by of to its Immunol. 2019; 10: PubMed Scopus Google Scholar TonEBP the phenotype of macrophages. the of TonEBP in macrophages, we TonEBP is involved in the pathogenesis of SLE. found that patients with LN renal TonEBP expression in infiltrating immune cells, macrophages and cells, as well as renal expression of proinflammatory mouse model of SLE that TonEBP in macrophages to by efferocytosis and T-cell differentiation. TonEBP is induced by damage-associated molecular patterns in mediates activation of and target of factor leading to expression of inflammatory cytokines and data that TonEBP may be an regulator for the pathogenesis of SLE and LN. patients with LN kidney biopsy and patients with or lupus nephritis a of kidney biopsy control patients disease. biopsy from patients with LN and for and mRNA patients to kidney biopsy to the with the of The for by the of a of The of patients with LN for and including and and Lupus and to the of S. et of the of for lupus of and of and 2018; Full Text Full Text PDF PubMed Scopus Google Scholar The Systemic Lupus an of lupus disease was on the of as C. et al.The on Studies in SLE. of the a disease for lupus Rheum. 35: PubMed Scopus Google Scholar the of and was by was to from kidney biopsy that in was from of a was a with The for samples in mRNA expression of target was to that of and the mRNA expression in the lupus nephritis compared with in the control the animals in with by the and of the of and TonEBP to the et a protein that in to A. PubMed Scopus Google Scholar and TonEBP C. of a for the in 2014; Google Scholar in myeloid cell from The and to with of TonEBP To a of pristane control or was by and and for data are expressed as the compared or as compared by an for was for The TonEBP expression and of DNA and was or as to of and for of data from the pristane-induced murine model and the in was we TonEBP a role in SLE and LN. In we to patients with LN. patients with or LN with control patients with disease. patients displayed the LN showed of and of the control The of the patients with LN are in LN with reduced elevated and for a of The from to and the SLE disease from to of the LN and the control nephritis as cell as LN, lupus expressed as as cell as in a of lupus nephritis patients in both in and mRNA expression and both in and mRNA expression both in and mRNA expression in mRNA expression in mRNA expression and in mRNA expression and in and in and in in in in DNA Systemic Lupus both in and mRNA expression in mRNA expression in in in a LN, lupus expressed as DNA Systemic Lupus expression of TonEBP, of proinflammatory S. et DNA TonEBP mediates inflammation and loss as transcriptional cofactor for and PubMed Scopus Google Scholar is the of in S. S.A. et is a regulator of inflammatory Rheum. 2011; PubMed Scopus Google S. S. D. et factor promotes macrophage in PubMed Scopus Google Scholar and et enhancer-binding protein promotes and 2019; PubMed Scopus Google Scholar we mRNA expression encoding TonEBP and cytokines in kidney biopsy TonEBP mRNA expression was in the LN in the control of and mRNA was also in the LN In expression of and mRNA correlated with that of TonEBP mRNA is consistent with the role of TonEBP in of proinflammatory The protein of these cytokines also to be in the LN in the control the was the of TonEBP mRNA correlated with the degree of and showed a a with we to renal TonEBP. TonEBP was in both nuclear and TonEBP was to a variety of cell types, including cells, cells, and in the of patients with LN. In the LN renal with immune cells. renal TonEBP was expressed in with and with the TonEBP expression was in and The of cells was in of the kidney and in the LN in the control Thus, renal protein expression of TonEBP is elevated in LN, in with its mRNA we immune to TonEBP expression to various renal and immune cells. The of cells was elevated in the LN and The was in both and cells. The was with the immune cells and and T cells, T cells, macrophages, and macrophages. we renal B cells, cells, and macrophages, the of these cells In TonEBP expression is elevated in renal cells and infiltrating immune cells, including T cells and macrophages, in LN. we renal expression of TonEBP. To we a mouse model of SLE induced by a of pristane C. S. et models of Immunol. 6: PubMed Scopus Google et of autoimmunity by pristane and other Immunol. 2009; Full Text Full Text PDF PubMed Scopus Google Scholar compared TonEBP with is animals are to induced S. S.A. et is a regulator of inflammatory Rheum. 2011; PubMed Scopus Google Scholar and S. et enhancer-binding protein mediates inflammation and and renal 2018; PubMed Scopus Google Scholar displayed a elevated of and renal and injury in with deposition of and In renal expression of TonEBP was elevated and to patients with LN. phenotype was from TonEBP that TonEBP may be involved in the development of SLE and associated renal was immune complex deposition in the of TonEBP as well as the of suggesting that systemic for the development of SLE are To the systemic we and immune cell in the and pristane was was by TonEBP of inflammatory the was of cells, and macrophages was Thus, we that TonEBP in myeloid cells is associated with the pathogenesis of SLE and LN. Myeloid TonEBP is required for cell et in cells mediates and Death Dis. PubMed Scopus Google Scholar and macrophage S. S. D. et factor promotes macrophage in PubMed Scopus Google Scholar in that we elevated TonEBP in macrophages in patients with LN and and its role in systemic immune responses with reduced in myeloid cell populations in pristane-induced TonEBP we the role of myeloid TonEBP with of TonEBP and found that with of TonEBP SLE and LN to with TonEBP renal TonEBP expression was also in with myeloid TonEBP deficiency and we TonEBP deficiency in myeloid cells immune cell populations in the animals pristane kidney was with an in the of was in a and the of macrophages or in animals was in and expression of and costimulatory molecules and is for and T-cell differentiation induced by antigen-presenting cells. of and on the of cell was elevated in the in to pristane was in cells from the animals expression of or was in cells and pristane the of infiltrating macrophages in kidney from with TonEBP was that in is consistent with a of to T cells by antigen-presenting cells and differentiation of T cells, a in the pathogenesis of SLE. myeloid TonEBP is required for of antigen-presenting cells and expression of molecules associated with we myeloid TonEBP to T-cell differentiation. we cell subsets from pristane the of B cells was reduced by TonEBP of and T-cell populations of T cells a reduced of cell and cell cells in TonEBP-deficient mice, with in the cell and T-cell populations and renal expression was consistent with in differentiation and of cytokines and as well as and was and renal expression of phenotype genes and to in TonEBP-deficient and Thus, myeloid TonEBP deficiency is associated with of T-cell differentiation to the Th1 or Th17 as well as of inflammatory responses. is consistent with the of these animals to pristane-induced SLE. To the role of TonEBP in myeloid cells, we to macrophages. macrophages from and with TLR4 or TLR9 S.A. Hoi A. Steinmetz O.M. et al.TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.J Autoimmun. 2010; 35: 291-298Crossref PubMed Scopus (102) Google L. et of TLR4 TLR9 and with risk for systemic lupus erythematosus PubMed Scopus (31) Google Scholar E. Steinberg C. Pawar R.D. et al.Requirement of toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.Arthritis Rheum. 2008; 58: 1107-1115Crossref PubMed Scopus (116) Google Wang et human PubMed Scopus Google N. et of toll-like receptor 7 with systemic lupus A. 2010; PubMed Scopus Google Xie C. J. et expression of toll-like receptors (TLRs) 7 and and other cytokines in systemic lupus erythematosus (SLE) and for therapeutic Immunol. 2014; PubMed Scopus Google Scholar and P.S. Zecher D. Pawar R.D. et al.G-rich DNA systemic PubMed Scopus Google Xie C. J. et expression of toll-like receptors (TLRs) 7 and and other cytokines in systemic lupus erythematosus (SLE) and for therapeutic Immunol. 2014; PubMed Scopus Google Scholar form a of the receptor for damage-associated molecular patterns and in the pathogenesis of SLE. found that these induced expression of proinflammatory cytokines associated with differentiation and in a as in of the with The of of and genes and was also associated with elevated expression of TonEBP and promotes expression of molecules involved in toll-like activation and by macrophages. macrophages from or with B or for expression of or major histocompatibility complex was by and are of cell expression of and was In we to the molecular the of TonEBP. we of TonEBP is associated with activation of the TonEBP promoter. To we a an human TonEBP and expression of TonEBP in cells data that engagement of TLRs TonEBP expression via the promoter. we examined activation of and of and these molecules are involved in the pathogenesis of A. M. and systemic lupus the 2013; PubMed Scopus Google Scholar, et of nuclear can the susceptibility to systemic lupus 2009; PubMed Scopus Google Scholar, K. D. et factor as of the in cells from systemic lupus erythematosus in the Immunol. 2014; PubMed Scopus Google Scholar, S. et factor to the with expression in systemic lupus erythematosus.Arthritis Rheum. 2012; PubMed Scopus Google Scholar, et the is associated with and in lupus Rheum. 2010; PubMed Scopus (135) Google Scholar, J. et of a with systemic lupus erythematosus.Arthritis Rheum. 2011; PubMed Scopus Google Scholar show that TonEBP the transcriptional of in to by as a cofactor for TonEBP in the to the of via protein-protein S. et DNA TonEBP mediates inflammation and loss as transcriptional cofactor for and PubMed Scopus Google Scholar Here, we TonEBP in to other TLR In cells, and induced and mRNA as well as TonEBP in with activation of and In of TonEBP blocked of mRNA expression encoding cytokines and activation of nuclear and DNA of by TonEBP and is consistent with the role of TonEBP as a transcriptional also examined mouse cells from in the of the is of it with S. et DNA Scholar In these cells, activation of in to TLR was blocked and the was the data that TonEBP in to TLR via protein-protein with also examined and in cells by TLR mRNA expression of a by and was by TLR in a of was by and of was by and in a and To the molecular of we to explore to the TonEBP et in to DNA through with and 2019; Full Text Full Text PDF PubMed Scopus Google Scholar it is a regulator of the S. et of in cells the Immunol. 2008; 9: PubMed Scopus Google C. D. K. et al.The in to and innate immune J. 2018; PubMed Scopus Google Scholar we the in the TLR of and its downstream target in a and To the role of TonEBP, we expressed various of TonEBP in cells, in TonEBP TonEBP in to the TLR a TonEBP the and data that TonEBP mediates activation of in to TLR engagement in a dependent on its the of apoptotic cell clearance in the pathogenesis of M. Voll R.E. Zoller O.M. et al.Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus.Arthritis Rheum. 1998; 41: 1241-1250Crossref PubMed Scopus (721) Google Scholar, 6Gaipl U.S. Munoz L.E. Grossmayer G. et al.Clearance deficiency and systemic lupus erythematosus (SLE).J Autoimmun. 2007; 28: 114-121Crossref PubMed Scopus (242) Google Scholar, 7Munoz L.E. Chaurio R.A. Gaipl U.S. et al.MoMa from patients with systemic lupus erythematosus show altered adhesive activity.Autoimmunity. 2009; 42: 269-271Crossref PubMed Scopus (13) Google Scholar we examined the role of TonEBP in efferocytosis by we expression of molecules and and that receptors and for C. et cells clearance and immune through activation of the nuclear receptor 2009; Full Text Full Text PDF PubMed Scopus Google L. et and clearance of apoptotic cells to 2009; PubMed Scopus Google Scholar TonEBP-deficient displayed expression of genes associated with these and molecules in to TLR we phagocytosis of apoptotic cells by and found that TonEBP-deficient and data that TonEBP in macrophages of apoptotic cells in with expression of genes to In the data from that TonEBP in macrophages to the pathogenesis of by autoimmune and cell development via activation and and efferocytosis The data that TonEBP may be an in SLE. of TLRs TLR7/8, and by damage-associated molecular patterns is an in the pathogenesis of SLE in both S.A. Hoi A. Steinmetz O.M. et al.TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.J Autoimmun. 2010; 35: 291-298Crossref PubMed Scopus (102) Google Scholar, 12Savarese E. Steinberg C. Pawar R.D. et al.Requirement of toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.Arthritis Rheum. 2008; 58: 1107-1115Crossref PubMed Scopus (116) Google Scholar, 13Patole P.S. Zecher D. Pawar R.D. et al.G-rich DNA systemic PubMed Scopus Google Scholar and L. et of TLR4 TLR9 and with risk for systemic lupus erythematosus PubMed Scopus (31) Google Scholar, et in toll-like receptors are associated with systemic lupus erythematosus in a 2014; PubMed Scopus Google Scholar, A. et toll-like receptors are associated with systemic lupus erythematosus in a of 2014; PubMed Scopus Google Scholar, Wang et human PubMed Scopus Google Scholar found that the TonEBP in macrophages is by of these activated leading to expression of TonEBP. is required for the pathogenesis of SLE. of TonEBP is also for S. S. D. et factor promotes macrophage in PubMed Scopus Google Scholar and et in cells mediates and Death Dis. PubMed Scopus Google Scholar in Thus, myeloid TonEBP to be a stress protein to autoimmune and In TonEBP the leading to activation of macrophages and S. S. D. et factor promotes macrophage in PubMed Scopus Google Scholar and the of cells for et in cells mediates and Death Dis. PubMed Scopus Google Scholar that macrophage TonEBP promotes SLE via TonEBP efferocytosis by the expression of molecules involved in to of cells and autoimmune transcriptional and are by TonEBP, leading to differentiation and macrophage TonEBP with the of and its transcriptional TonEBP with leading to of Elevated TonEBP expression is associated with inflammatory including S. S.A. et is a regulator of inflammatory Rheum. 2011; PubMed Scopus Google S. S. D. et factor promotes macrophage in PubMed Scopus Google Scholar S. et enhancer-binding protein mediates inflammation and and renal 2018; PubMed Scopus Google Scholar et enhancer-binding protein promotes and 2019; PubMed Scopus Google Scholar and TonEBP mediates inflammation and loss as transcriptional cofactor for and PubMed Scopus Google Scholar TonEBP leads to of proinflammatory genes via stimulation of by S. et DNA Scholar Here, we found that is in LN as TonEBP expression was elevated in cell types in the kidney of patients and TonEBP expression with the degree of that TonEBP to renal injury via data that TonEBP may be involved in the pathogenesis of as well as renal via local The of SLE In the TonEBP animals was is the that these animals are also to induced S. S.A. et is a regulator of inflammatory Rheum. 2011; PubMed Scopus Google Scholar S. et enhancer-binding protein mediates inflammation and and renal 2018; PubMed Scopus Google Scholar and et enhancer-binding protein promotes and 2019; PubMed Scopus Google Scholar is that a of TonEBP expression in myeloid cells is for TonEBP in cell be data from patients with LN and murine model and the of autoantibodies by TonEBP a role of TonEBP in T and B cells. it that of TonEBP is to TonEBP may be a target for LN the of a of pristane-induced in the in other that as the present that TonEBP be an attractive for or of SLE also LN. the of TonEBP, be of the TonEBP or with and interactions. of In that myeloid TonEBP mediates cellular involved in the pathogenesis of SLE and LN. TonEBP is also involved in and other autoimmune The role of TonEBP as an immunometabolic stress Rev PubMed Scopus Google Scholar it may be a therapeutic target as a autoimmune the The human by the the of of and for of the was by the of by the and with expression of TonEBP mRNA and proinflammatory cytokines in patients with lupus nephritis (LN). of proinflammatory cytokines in by from kidney biopsy samples of patients with LN and control mRNA of TonEBP by compared with of renal mRNA expression of TonEBP and of lupus and of DNA and mRNA expression of TonEBP to of to of a biopsy from a with lupus nephritis (LN) for or TonEBP renal with TonEBP expression as well as and renal with TonEBP expression in the of TonEBP expression in various cell types from the of of cells to for both and compared with control TonEBP expression in and from the pristane-induced mouse model of and and renal mRNA and protein expression of TonEBP from and pristane or and renal mRNA and protein expression of TonEBP from and pristane or or TonEBP of myeloid cell of and and of the of inflammatory and cells in subsets from cells and of the cell populations of macrophages, T cells, T cells, and B cells from and Myeloid TonEBP and of cells. and from and pristane or from of cells in was by expression of or major histocompatibility complex in cells was by and was TonEBP expression in renal infiltrating macrophages in pristane-induced lupus was with kidney from and of pristane for and TonEBP macrophages. of B cells and T cells in pristane-induced lupus from and by pristane as in of B cells T cells and T cells T-cell Myeloid TonEBP deficiency immune responses in of pristane-induced lupus and from and or pristane mRNA expression encoding TonEBP, and cell cell cytokines and and phenotype and was by mRNA expression encoding TonEBP, and cytokines and and phenotype and was by TonEBP promotes nuclear factor transcriptional nuclear and DNA of cells with or TonEBP mRNA expression of TonEBP, and was with or for cells with an was of with or with by stimulation with or for and nuclear the nuclear and for TonEBP, or with by stimulation with or for to DNA of to an TonEBP with and signaling in a cells with a and for with or by of and TonEBP of with or of or to or cells with TonEBP by with or expression for or TonEBP. The cells with or for of to TonEBP TonEBP TonEBP
37
Derivation of the sledai. A disease activity index for lupus patients
Claire Bombardier, Dafna D. Gladman, Murray B. Urowitz et al. · Arthritis & Rheumatism · 1992 · 4.6K citations
Ingeborg M. Bajema, Suzanne Wilhelmus, Charles E. Alpers et al. · Kidney International · 2018 · 1K citations · Full text
Medicine, Nephrology, Pathology +10